Cargando…

Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma

Detalles Bibliográficos
Autores principales:	Ashraf, Anam, Eslam, Mohamed, Lam, Weyman, Avila, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804461/ http://dx.doi.org/10.1016/j.jaci.2021.12.603

Ejemplares similares

The Role of Dupilumab in Severe Asthma
por: Ricciardolo, Fabio Luigi Massimo, et al.
Publicado: (2021)

Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection
por: Newell, Krista L, et al.
Publicado: (2022)

Severe pediatric asthma therapy: Dupilumab
por: Ferrante, Giuliana, et al.
Publicado: (2022)

Orbital mucormycosis – Post SARS-CoV-2 sequelae
por: Mobeen, Hafsa, et al.
Publicado: (2021)

Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women
por: Price, Jillian Kallman, et al.
Publicado: (2023)

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
por: Ragnoli, Beatrice, et al.
Publicado: (2022)

Successful treatment with dupilumab for mucus plugs in severe asthma
por: Anai, Moriyasu, et al.
Publicado: (2022)

The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection
por: Moghimi, Narges, et al.
Publicado: (2021)

Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2
por: Mahmoud, Zainab, et al.
Publicado: (2022)

Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST
por: Maspero, Jorge F., et al.
Publicado: (2021)

Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: a case report
por: Agnihotri, Shruti P., et al.
Publicado: (2022)

Dupilumab in the management of moderate-to-severe asthma: the data so far
por: Barranco, Pilar, et al.
Publicado: (2017)

Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review
por: Rathinam, Kiran Kumar, et al.
Publicado: (2019)

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023)

Post-acute Sequelae of SARS-CoV-2 Infection and Subjective Memory Problems
por: Oh, Esther S., et al.
Publicado: (2021)

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
por: Sherif, Zaki A, et al.
Publicado: (2023)

Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection
por: Chiba, Shiho, et al.
Publicado: (2021)

A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2
por: Singh, Tamanna K., et al.
Publicado: (2023)

Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
por: Castro, Mario, et al.
Publicado: (2020)

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
por: van Dijk, Yoni E., et al.
Publicado: (2023)

Dupilumab: a novel treatment for asthma
por: Vatrella, Alessandro, et al.
Publicado: (2014)

Association Between SARS-CoV-2 RNAemia and Post-Acute Sequelae of COVID-19.
por: Ram-Mohan, Nikhil, et al.
Publicado: (2021)

Longitudinal evaluation of neurologic‐post acute sequelae SARS‐CoV‐2 infection symptoms
por: Shanley, Jacqueline E., et al.
Publicado: (2022)

Autonomic Nerve Involvement in Post-Acute Sequelae of SARS-CoV-2 Syndrome (PASC)
por: Chung, Tae Hwan, et al.
Publicado: (2022)

Post-acute Sequelae of SARS-CoV-2 Infection: Do Indians Fare Better?
por: Lakshmanan, Suja, et al.
Publicado: (2022)

SARS-CoV-2 infection sequelae on exercise response: persistent or reversible? A 2-year perspective
por: Rinaldo, Rocco Francesco, et al.
Publicado: (2023)

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection
por: Patterson, Bruce K., et al.
Publicado: (2022)

Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae
por: Popiela, Magdalena Z., et al.
Publicado: (2021)

Dupilumab efficacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis
por: Zaazouee, Mohamed Sayed, et al.
Publicado: (2022)

Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection
por: Pinto, Melissa D., et al.
Publicado: (2022)

Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection
por: Dmytrenko, Oleksandr, et al.
Publicado: (2022)

Postacute Sequelae of SARS-CoV-2 in University Setting
por: Landry, Megan, et al.
Publicado: (2023)

Possible sequelae in post-SARS-CoV-2 patients: effects on sleep and general health condition
por: Vitti-Ruela, Bárbara Virginia, et al.
Publicado: (2020)

Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care
por: Parker, Ann M, et al.
Publicado: (2021)

Symptoms After COVID-19 Vaccination in Patients with Post-Acute Sequelae of SARS-CoV-2
por: Nehme, Mayssam, et al.
Publicado: (2022)

Why obesity and psychological stress matter in recovery of post‐acute sequelae of SARS‐CoV‐2
por: Carter, Stephen J., et al.
Publicado: (2022)

The unique contribution of depression to cognitive impairment in Post-Acute Sequelae of SARS-CoV-2 infection
por: Brown, Lily A., et al.
Publicado: (2022)

Age Differences in Becoming COVID Long-Haulers and in Post-Acute Sequelae of SARS-CoV-2
por: Wu, Qiao, et al.
Publicado: (2021)

Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue
por: Wang, Zhonglei, et al.
Publicado: (2022)

Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural orthostatic tachycardia syndrome
por: Diekman, Sarah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_206hj65v4qs4ib7fq4ff28fi07